Abstract

[...]reports of prevalence, clinical consequence, and pathogenesis are needed. [...]the highly variable morphological characteristics of LH in terms of size, texture, and prominence of the skin also make diagnosis difficult [Table 1]. [24] Already known risk factors of LH include high body mass index, frequency of needle reuse, failure to alternate injection sites and internal rotations, frequency of daily injections, length of the needle, duration of insulin therapy, high hemoglobin A1c, and patients with hypoglycemia.

Details

Title
Lipohypertrophy: prevalence, clinical consequence, and pathogenesis
Author
Xiao-Han, Xu; Carvalho Vladmir; Xiao-Hang, Wang; Shan-Hu, Qiu; Zi-Lin, Sun
Pages
47-49
Section
Perspective
Publication year
2021
Publication date
Jan 2021
Publisher
Lippincott Williams & Wilkins Ovid Technologies
ISSN
03666999
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2480944288
Copyright
Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.